Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
Mehnert JM, Bergsland E, O'Neil BH, Santoro A, Schellens JHM, Cohen RB, Doi T, Ott PA, Pishvaian MJ, Puzanov I, Aung KL, Hsu C, Le Tourneau C, Hollebecque A, Élez E, Tamura K, Gould M, Yang P, Stein K, Piha-Paul SA. Mehnert JM, et al. Among authors: bergsland e. Cancer. 2020 Jul 1;126(13):3021-3030. doi: 10.1002/cncr.32883. Epub 2020 Apr 22. Cancer. 2020. PMID: 32320048 Clinical Trial.
Immune enhancement of skin carcinogenesis by CD4+ T cells.
Daniel D, Meyer-Morse N, Bergsland EK, Dehne K, Coussens LM, Hanahan D. Daniel D, et al. J Exp Med. 2003 Apr 21;197(8):1017-28. doi: 10.1084/jem.20021047. Epub 2003 Apr 14. J Exp Med. 2003. PMID: 12695493 Free PMC article.
119 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page